Skip to main content
Professional Technical IVT

Stevens-Johnson syndrome

Pronunciation: STEE-vens JOHN-son syndrome

Also written as: SJS — Stevens-Johnson syndrome

A severe mucocutaneous reaction characterized by widespread epidermal necrosis and detachment, often drug-induced and potentially life-threatening.

Full Definition

Stevens-Johnson syndrome (SJS) is a rare but serious mucocutaneous disorder representing the milder end of the SJS/toxic epidermal necrolysis spectrum, with less than 10% body surface area involvement. The condition typically begins with flu-like symptoms followed by painful mucosal erosions and a spreading erythematous rash that progresses to vesicles, bullae, and epidermal detachment. In children, SJS is most commonly triggered by medications such as sulfonamides, anticonvulsants, and NSAIDs. Early recognition and discontinuation of the offending agent are crucial for preventing progression to more severe disease.

Usage

Usage note: Always document the suspected triggering medication and percentage of body surface area affected.

In Context

  • "The child developed Stevens-Johnson syndrome three days after starting trimethoprim-sulfamethoxazole." — Emergency department presentation
  • "Immediate discontinuation of all medications was ordered upon suspicion of Stevens-Johnson syndrome." — Urgent care protocol

Also known as

SJS

Don't confuse with

toxic epidermal necrolysis erythema multiforme staphylococcal scalded skin syndrome

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON